Xiao Hui, Zhou Wen-Hao
Department of Neonatology, Children's Hospital, Fudan University, Shanghai 201102, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Oct;22(10):1138-1142. doi: 10.7499/j.issn.1008-8830.2005004.
Gene panel and whole exome sequencing are now commonly used to detect Mendelian disease, but the current molecular diagnostic rate of DNA sequencing is only 35%-50%. In recent years, RNA sequencing emerges as a promising diagnostic method. It can detect new pathogenic mutations, and analyze allele-specific expression. This will be helpful to understand the relationship between disease genotype and phenotype, and can complement genome sequencing in order to expand the traditional genomic diagnostic methods of Mendelian disease. RNA sequencing is expected to become a routine tool for diagnosing Mendelian diseases. This article reviews the application of RNA sequencing in the clinical diagnosis of Mendelian disease.
基因检测板和全外显子组测序现在常用于检测孟德尔疾病,但目前DNA测序的分子诊断率仅为35%-50%。近年来,RNA测序成为一种有前景的诊断方法。它可以检测新的致病突变,并分析等位基因特异性表达。这将有助于理解疾病基因型与表型之间的关系,并且可以补充基因组测序,以扩展孟德尔疾病的传统基因组诊断方法。RNA测序有望成为诊断孟德尔疾病的常规工具。本文综述了RNA测序在孟德尔疾病临床诊断中的应用。